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Monoclonal antibodies were prepared to the y-subunit of the cGMP phosphodiesterase. One of them yp-I, suppresses 
the activation of phosphodiesterase through the a-subunit of transducin. The y-subunit fragment 24-45 rich in Arg and 
Lys residues is involved in yp-1 binding and is essential for the y-subunit interaction with transducin. Carboxypeptidase 
Y cleaves off seven amino acid residues from the C-terminus of the y-subunit resulting in phosphodiesterase activation. 
Thus, the C-terminal fragment of y-subunit participates in phosphodiesterase inhibition. 
Cyclic-GMP phosphodiesterase; Transducin; Monoclonal antibody; Carboxypeptidase Y 
1. INTRODUCTION 
The y-subunit of retinal cyclic GMP 
phosphodiesterase (PDE) plays a leading role in 
photoinduced activation of PDE which decreases 
the cGMP content in the photoreceptor cell and, 
consequently, changes the Na+ permeability of the 
plasma membrane [1,2]. Besides, the y-subunit 
was found in no tissues [3] except for retina [4,5]. 
We showed that the amino acid sequence of the y- 
subunit of PDE carried a special site considerably 
enriched in basic amino acids [6] and focused at- 
tention on the functioning of the site in regulation 
of PDE activity. 
Still little is known about the PDE system in the 
photoreceptor cell though it has been intensively 
studied. For example, PDE can be modified by 
cGMP binding to PDE at distance from the 
catalytic site and by methylation of the enzyme’s 
catalytic subunit [7-91. The y-subunit of PDE 
regulates both the processes. However, their in- 
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volvement in the mechanism of photoreception has 
not yet been established. The chemical bases 
underlying the interaction between the y-subunit 
of PDE and the enzyme’s catalytic subunits, on the 
one hand, and the a-subunit of transducin upon 
the enzyme activation, on the other, are also 
unknown. This paper presents the data on localiza- 
tion of the regions (active sites) providing a variety 
of y-subunit functions. Preliminary results were 
published in [ 141. 
2. MATERIALS AND METHODS 
The fraction of rod outer segments (ROS) from bovine 
retinas was isolated according to [15]. PDE and the y-subunit 
were isolated and purified as in [6,15]. The y-subunit was 
cleaved with Staphylococcus aureus protease, trypsin and 
cyanogen bromide to give peptides S-2, T-l 1, and CB-1, CB-2, 
CB-3, respectively. Peptides SP-1 and SP-2 were synthesized. 
PDE and the y-subunit were treated with carboxypeptidase Y 
in a buffer solution (50 mM Tris-HCI, pH 8.0, 1 mM 
2-mercaptoethanol, 2 mM MgC12) for 15-30 min at 37°C. 
Monoclonal antibodies were obtained as in [16] using 
BALB/c mice for immunization. The thermally treated PDE 
preparation extracted from ROS was used for injections. The 
immunization scheme was the following: the first injection, 
30 pg of protein per mouse, subcutaneously; 20 days later the 
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second subcutaneous injection, 50pgImouse; in 10 days the 
third injection, 50 gg/mouse, intraperitoneally; the same injec- 
tion was repeated in 2 weeks; 2 weeks later three daily booster 
injections, 50 pg/mouse, each intraperitoneally. Splenocytes of 
immunized mice were hybridized with cells of mice myeloma 
2/O-Ag 14 on a day after the last immunization. Screening of 
hybridomas and an investigation of the interaction of peptides 
with the antibody were carried out by ELISA, using an elec- 
trophoretically homogeneous y-subunit. Monoclonal an- 
tibodies were isolated from the ascites liquid and purified on 
protein A-Sepharose [ 171. 
The PDE activity was determined by the isotopic method and 
using 5 ’ nucleotidase [ 181. Photoinduced activation of PDE 
was tested in the presence of GTP and its nonhydrolyzable 
analogue Gpp(NH)p [19]. High affinity GTPase of rod outer 
segments was detected at a substrate concentration of 5 x 
lo-’ M [20]. 
3. RESULTS AND DISCUSSION 
Initially monoclonal antibodies to the y-subunit 
of PDE were produced and only one of them, 
yp-1, was selected. In the presence of GTP and its 
nonhydrolyzable analogue Gpp(NH)p the photoin- 
duced activation of PDE was virtually suppressed 
by monoclonal antibody yp-1 (fig. l), but the basal 
enzyme activity remained the same. Here the 
GTPase activity intrinsic to transducin, and in par- 
ticular to its a-subunit, was also retained (not 
shown). Thus to provide the PDE photoinduced 
activation, the y-subunit has a special antibody- 
blocked site. Immunoglobulins attached to the y- 
subunit site prevent the contact of the latter with 
the a-subunit of transducin, but do not affect 
other features, in particular, the GTPase activity. 
10 20 30 
AntIbody. j.19 
Fig.1. Influence of monoclonal antibody yp-1 on basal activity 
of PDE (0.25 pg of protein) (0) and PDE photoinduced 
activation in ROS preparations (10/g of protein) in the 
presence of GTP (0) or Gpp(NH)p (A). Concentration of GTP 
and Gpp(NH)p, 5 x 10-s M. Gpp(NH)p (lo-’ M). 
Fig.2. Influence of peptide SP-1 (24-47) (0.08 nmol) on PDE 
activity in ROS (10 pg of protein). 1, basal activity of PDE in 
ROS; 2, PDE activity in ROS in the presence of peptide SP-1; 
3, PDE activity in ROS in the presence of Gpp(NH)p (10m5 M); 
4, PDE activity in ROS in the presence of peptide SP-1 and 
Table 1 
Interaction of monoclonal antibody yp-1 and PDE y-subunit 
peptides 
Peptide and its positioning 
in the molecule 
Interactiona 
BC-1 (2-17) 
BC-2 (18-57) 
BC-3 (58-87) 
T-l 1 (46-87) 
s-2 (10-58) 
SP-1 (24-47) 
SP-2 (24-35) 
yCPk;” (l-8& + 
a +, Strong interaction; +, weak interaction; -, no 
interaction 
b ?CPY, Carboxypeptidase treated y-subunit 
The protein region responsible for its interaction 
with the enzyme’s catalytic subunits remains 
intact. 
ELISA of some peptides revealed the site of in- 
teraction with monoclonal antibody yp-1 on the y- 
subunit molecule. Only the peptides composed of 
the region enriched in basic amino acids (24-45) 
(table 1) interact with the antibody, i.e. this region 
is necessary for binding to transducin and, respec- 
tively, for photoinduced activation of PDE. 
The following experiments provided additional 
evidence of the important role of this region 
(24-45) of the y-subunit of PDE in the enzyme 
loo- 
25- 
3 
1 
4 
1 2 
Ti 
288 
Volume 234. number 2 FEBS LETTERS July 1988 
I I 
20 40 60 
Tune (man) 
Fig.3. Carboxypeptidase Y activation of purified PDE (0.25 pg 
of protein) (A) and PDE in ROS preparation (10 pg of protein) 
(0). 
photoactivation. In the presence of peptide SP-1 
(amino acid sequence 25-47) and Gpp(NH)p no 
photoinduced activation of PDE was observed 
(fig.2), probably due to competition of the peptide 
and the y-subunit when interacting with the a- 
subunit of transducin. 
Which site of the y-subunit of the PDE molecule 
interacts with the catalytic subunits inhibiting en- 
zyme activity? Treatment of PDE with carbox- 
ypeptidase Y was found to cause potent enzyme 
activation (fig.3). Treatment of ROS with carbox- 
ypeptidase Y also results in the activation cor- 
related with the PDE photoinduced activation in 
the presence of guanyl nucleotides (fig.4). Besides, 
addition of the carboxypeptidase Y-treated y- 
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Fig.4. Activation of PDE with carboxypeptidase Y and light. 1, 
purified PDE (0.25 pg); 2, PDE (0.25 pg) plus y-subunit 
(0.05 pg); 3, PDE (0.25 pg) plus CPY (5 pg); 4, PDE (0.25 pg) 
plus yCPY (0.05 pg); 5, ROS (10 pg of protein); 6, ROS (10 pg 
of protein) plus Gpp(NH)p (5 x 10m5 M); 7, ROS (1Ogg of 
protein) plus CPY (5 Fg). 
subunit ($PY) to purified PDE induces no inhibi- 
tion of the enzyme activity as in the case of the in- 
tact y-subunit (fig.4). Upon treatment of the 
y-subunit with carboxypeptidase Y seven amino 
acid residues (1 Gln, 1 Ala, 1 Gly, 2 Ile, 1 Leu, 1 
Tyr) are cleaved off from the C-terminus. The 
results of the experiments imply participation of 
the y-terminal amino acid residues in the PDE in- 
hibition. 
Thus the C-terminal fragment and the basic 
region in the middle of the y-subunit polypeptide 
chain (24-45) are functionally active sites. The 
first participates in PDE inhibition and the second 
in the y-subunit-transducin interaction. Enzyme 
activation upon trypsinolysis [lo] indicates that 
this basic region may also be involved in the in- 
teraction with the enzyme’s catalytic subunits. The 
functional role of other regions of the y-subunit of 
PDE is under investigation. 
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